USX:PRAH - PRA Health Sciences Inc (USD 72.96) PRA Health Sciences Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance

USD 72.96    -3.290 (-4.31%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

3 Apr 2020


Overview

3 Apr 2020

Day Change: -3.290 (-4.31%)

52 Wk Range: 58.67 - 113.1

Day's Range: 71.46 - 77.36

Last Volume: 716,403

Current Yield: 0%

Projected Yield: 0%

Open: USD 75.23

3 Apr 2020

Metric PRAH S.Median
Beta 1.21 0.77
VaR 23.12 46.1
E.Shortfall 39.16 76.92
Liquidity 445.34K 22.95K

Fundamental

3 Apr 2020

PE: 19.808

Market Cap: 4.8B

Price Over Book: 4.418

Price Over Sales: 1.57

Return On Assets: 6.9%

Return On Equity: 22.3%

NAV Over Price: [Friends Only]

General

CEO: Colin Shannon

Headquarters: Raleigh

Employees: 16,400

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development services to the biotechnology and pharmaceutical industries worldwide. The company offers integrated services, such as data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It also provides product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. The company's services also comprise strategic solutions comprising embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services consisting of Phase I through Phase IIa studies and bioanalytical laboratory services. It conducts clinical trials in the areas of pharmaceutical development, including oncology, central nervous system, inflammation, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. The company was founded in 1976 and is headquartered in Raleigh, North Carolina.